Chiral and specialty building blocks: Correlation
Prices it moves with, and why
Chiral and specialty building blocks are single-handed molecules and complex fragments used to make modern drugs and agrochemicals. Prices depend on synthesis difficulty, catalyst and enzyme costs, and patent-driven demand rather than bulk raw materials.
No public price Chiral and specialty building blocks has no public monthly price series: Niche, made-to-order chemicals; prices are quoted privately.What its price moves with
Most new small-molecule drugs are single enantiomers, so their APIs need chiral building blocks. Demand follows drug launches and patent expiries, and Indian CDMOs increasingly supply both the blocks and the APIs.
Not enough overlapping price history to measure.Chiral building blocks are a high-value subset of pharma intermediates, made by many of the same suppliers. They are less exposed to Chinese commodity-style price swings than bulk starting materials.
Not enough overlapping price history to measure.Natural amino acids are cheap, ready-made chiral molecules, so they are used as starting points for many building blocks. Large-scale fermentation keeps their cost low compared with synthetic routes, which makes them a natural first choice for chemists.
No public price for amino acids (lysine, methionine), so the link is explained in words only.Engineered enzymes are now a major way to make chiral molecules, replacing metal catalysts in many routes, such as in sitagliptin manufacture. Enzyme cost and performance set the cost of these routes.
No public price for industrial enzymes, so the link is explained in words only.Sugars and other fermentation products provide chiral starting materials and feed the microbes that make enzymes. Sugar costs are small next to the value of the finished building blocks, so sugar prices barely affect their pricing.
Not enough overlapping price history to measure.Asymmetric hydrogenation often uses rhodium or ruthenium catalysts. Rhodium's very high and volatile price makes recovering and recycling the catalyst essential, and has encouraged drug makers to switch to enzyme routes where possible.
No public price for rhodium, so the link is explained in words only.How to read these numbers
Correlation of monthly changes (the number in the coloured pill) compares how much each price moved, month by month, since 2006 or the first month both series exist. It runs from −1 to +1: near +1 the two usually rise and fall in the same months, near 0 there is no link, and a negative number means they tend to move in opposite directions. Above 0.7 is strong, 0.4 to 0.7 moderate, 0.2 to 0.4 weak.
12-month changes compare year-on-year moves, which shows whether two prices share the same cycles even when the month-to-month noise differs.
Price function is a straight-line fit of the two prices on logarithmic scales: price ≈ k × (partner price)β. β is how much this price moves, in per cent, for a 1% move in the partner over the whole period, and R² is the share of the variation the fit explains. Two prices that both drift up with inflation can fit well without any real link, so read it together with the monthly correlation.
Lead or lag checks whether the monthly correlation is clearly higher when one price is shifted by 1 to 6 months.
Correlation is not cause. The reasons on each card explain the economic link; the numbers show how strongly it has shown up in prices. Proxy series are US producer price indexes or related prices and can blur the real link.
Data: World Bank Commodity Price Data (Pink Sheet), October 2026; US Bureau of Labor Statistics producer price indexes, IMF primary commodity prices and US EIA prices via FRED, Federal Reserve Bank of St. Louis, retrieved November 2026. Calculations by this site.